[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Technology](https://github.com/mm80843/T3.5/tree/pages/docs/Technology/index.md) >> Individual ID:PBN__Technology_265 

# __Testing protocols__

## Category to which it belongs

* [Enhanced and expanded array of diagnostic testing tools, technologies, and methods for widespread and reliable screening.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_183.md)

## Closest similar item

* [Advanced testing methods](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_1102.md)
* [Protocols](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_464.md)
* [Standardization of testing protocols](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_154.md)
* [Standardized protocols](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_37.md)
* [Standardized testing protocols](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_401.md)
* [Study protocol platforms](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_3307.md)
* [Testing](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_115.md)
* [Testing technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_801.md)
* [Testing technology](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_3786.md)
* [Uniformity of protocols](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2370.md)

## Risks linked to this technology

* [High covid-19 positivity rates among healthcare workers indicate increased risk of transmission within healthcare settings.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_1172.md)
* [Internationalisation of power supply may introduce compatibility issues and safety risks.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16348.md)
* [Lack of robust testing for innovative technologies and solutions may lead to deployment of unproven or flawed systems, increasing the risk of technological failures and negative impact on public health and safety.](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16789.md)
* [Lower testing frequency in previously sars-cov-2 infected participants versus the control group](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_16966.md)
* [Risk of ineffective anti-sars-cov-2 coatings](https://github.com/mm80843/T3.5/blob/pages/Risk/PBN__Risk_18993.md)

## This Technology belongs to this TechGroup

* [Healthcare](https://github.com/mm80843/T3.5/blob/pages/TechGroup/PBN__TechGroup_2.md)

## This Technology belongs to this TechSubgroup

* [Diagnostic testing](https://github.com/mm80843/T3.5/blob/pages/TechSubgroup/PBN__TechSubgroup_7.md)

## This Technology enables the following mitigations

* [Lower testing frequency](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_4531.md)

## This technology is mentioned by

* [A Surface Coating that Rapidly Inactivates SARS-CoV-2](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_615.md)
* [Ingram_covid-19_2021](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_619.md)
* [Madurai_elavarasan_restructured_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_199.md)
* [Parkinson_continuous_2019](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_664.md)
* [Pilz_contributions_2022](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_608.md)

